126.44
price up icon1.66%   2.06
after-market Handel nachbörslich: 126.44
loading

Repligen Corp Aktie (RGEN) Neueste Nachrichten

pulisher
Jun 16, 2025

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jun 16, 2025
pulisher
Jun 16, 2025

Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey

Jun 13, 2025
pulisher
Jun 11, 2025

Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 10, 2025
pulisher
Jun 04, 2025

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance

Jun 02, 2025
pulisher
May 31, 2025

Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus

May 31, 2025
pulisher
May 29, 2025

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World

May 29, 2025
pulisher
May 27, 2025

Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK

May 27, 2025
pulisher
May 22, 2025

Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance

May 22, 2025
pulisher
May 20, 2025

Repligen at RBC Capital Markets: Strategic Growth Insights - Investing.com Australia

May 20, 2025
pulisher
May 17, 2025

Insider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN) - GuruFocus

May 17, 2025
pulisher
May 17, 2025

Repligen Co. (NASDAQ:RGEN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 17, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Sells 1,039 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World

May 16, 2025
pulisher
May 16, 2025

Contrasting Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 16, 2025
pulisher
May 15, 2025

Pioneering innovation in bioprocessing: Repligen’s growing impact in the area and symbiotic relationship with WWETB - Business Post

May 15, 2025
pulisher
May 13, 2025

Why Repligen Corp Stock Might Make Sense If Bought Today - Stocksregister

May 13, 2025
pulisher
May 12, 2025

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 11, 2025

Stifel Financial Corp Grows Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

May 11, 2025
pulisher
May 08, 2025

Things To Consider Before Buying Repligen Corp (NASDAQ: RGEN) - Stocksregister

May 08, 2025
pulisher
May 08, 2025

Global Hollow Fiber Filtration Market Set to Witness - openPR.com

May 08, 2025
pulisher
May 08, 2025

M&A activity dominates Q1, nearly 99% total med-tech deal value - BioWorld MedTech

May 08, 2025
pulisher
May 08, 2025

Repligen (NASDAQ:RGEN) Upgraded to “Hold” at StockNews.com - Defense World

May 08, 2025
pulisher
May 07, 2025

Investor’s Toolkit: Key Ratios for Assessing Repligen Corp (RGEN)’s Performance - DWinneX

May 07, 2025
pulisher
May 07, 2025

Repligen Corporation to Present at Upcoming May Investor Conferences - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright - Defense World

May 06, 2025
pulisher
May 05, 2025

Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RG - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RGEN Stock News - GuruFocus

May 05, 2025
pulisher
May 03, 2025

Leerink Partnrs Has Pessimistic View of Repligen Q2 Earnings - Defense World

May 03, 2025
pulisher
May 02, 2025

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare - Insider Monkey

May 02, 2025
pulisher
May 01, 2025

There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - Sete News

May 01, 2025
pulisher
May 01, 2025

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’ - Insider Monkey

May 01, 2025
pulisher
May 01, 2025

Wolfe Research Upgrades Repligen (NASDAQ:RGEN) to “Outperform” - Defense World

May 01, 2025
pulisher
May 01, 2025

BlackRock, Inc. Reduces Stake in Repligen Corp: An In-Depth Anal - GuruFocus

May 01, 2025
pulisher
Apr 30, 2025

Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings) - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Wolfe Research Upgrades Repligen Corp (RGEN) to an Outperform from a Peer perform - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen (RGEN) Price Target Adjusted by RBC Capital Amid Market Trends | RGEN Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen: Q1 Earnings Snapshot - CT Insider

Apr 30, 2025
$77.89
price up icon 2.70%
$194.28
price up icon 2.61%
medical_instruments_supplies COO
$72.81
price up icon 2.32%
$65.33
price up icon 0.26%
medical_instruments_supplies BAX
$31.23
price up icon 3.14%
medical_instruments_supplies WST
$222.42
price up icon 1.65%
Kapitalisierung:     |  Volumen (24h):